Fund profile

Connecticut Innovations

United States

Leading

About

Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm, dedicated to supporting the state's innovative and high-growth companies. Founded in 1989, CI invests across various industries, including biotech, IT, cleantech, and advanced manufacturing. They manage several funds, including the $50 million Future Fund, which targets early-stage, tech-enabled startups with diverse teams, emphasizing underrepresented founders. Investment sizes range from $250,000 to $1.5 million. Notable investments from CI’s diverse portfolio include companies like Athletic Brewing, Budderfly, and Veradermics. The firm’s commitment to diversity is further highlighted by the ClimateTech Fund, a $100 million initiative to support climate and adaptation technology ventures aimed at decarbonization and job creation in Connecticut​. Leading the team is CEO Matt McCooe, who brings over 25 years of venture capital experience. Key team members also include Alison Malloy, Managing Director of Investments, who co-manages the Future Fund, and Konstantine Drakonakis, Managing Director for the ClimateTech Fund. Connecticut Innovations prioritizes companies that are willing to maintain a presence in Connecticut, leveraging co-investment opportunities to maximize growth potential and support from a network of experienced partners and advisors. Their holistic approach involves strategic guidance, financial backing, and extensive networking opportunities to ensure portfolio companies thrive

Details

Highlights

$732.6k

Historical average check

$126M

Historical max check

February 2025

Last investment date

326

Investments

Healthtech & Wellness

Software & Apps

Biotech

Legal & Professional services

Consumer Goods & Electronics

Hardware. Robotics & IoT

AI & Deep Tech

Social media

Data & Analytics

Education

CleanTech & Sustainability

Natural Resources

Transportation & Mobility

Energy & Utilities

Food & Beverage

Advertising & Marketing

Gaming

Pharma

Other

Funds that also invest in Biotech